On this page
What belongs in the CTD P.7 container-closure description?
Identify each proposed packaging configuration and its primary components, materials and relevant specifications. Include functional secondary components where appropriate. Connect that identity to the suitability assessment in P.2 and stability evidence in P.8; a component description alone does not establish compatibility, protection or delivery performance.
Before you begin
M4Q(R1) P.7. Device and combination-product obligations are not determined by this packaging heading alone.
What you will prepare: A packaging description that identifies the actual controlled components for every proposed presentation.
Define each configuration component by component
Gather the packaging bill of materials, specifications, drawings and material identities. Describe the primary components and their materials of construction; provide the applicable description, identification and critical dimensions, with drawings where appropriate. Include relevant noncompendial methods and validation. Name configurations consistently across strengths, fill volumes and presentations.
Separate components with protective or delivery functions from nonfunctional secondary packaging. The latter may need only a brief description under M4Q, while functional components need enough information to understand their role. Do not omit a light-protective carton or delivery component merely because it does not directly contact the formulation.
Keep description, suitability and stability connected
P.7 identifies and controls the system; P.2.4 explains its suitability for the product. Link the relevant evidence for protection, compatibility, material safety and delivery performance instead of duplicating conclusions in conflicting versions. Match the proposed configuration to P.8 stability and any P.2.6 use/compatibility studies.
If a system includes a device or accessory, identify it accurately but obtain the applicable regulatory assessment separately. This guide cannot establish all device requirements from a container description. Likewise, unknown resin, coating or elastomer information must be resolved through the supplier and packaging owner before claiming equivalence.
Worked review: one stopper description covers two formulations
Fictional exercise: two formulations use visually identical vial systems, and the draft reuses one P.7 description and compatibility conclusion. Supplier records show different stopper coatings.
Separate the component identities, confirm the proposed configurations, and ask the packaging/formulation owners to assess the applicability of the supporting studies. Reconcile P.2 and P.8 before combining information. Visual similarity is not evidence of material equivalence, and a correct component table does not establish suitability for both formulations.
Keep configurations distinguishable across the dossier
Build an editorial configuration register using the packaging bill of materials and the product presentation list.
| Configuration field | Record precisely | Cross-check |
|---|---|---|
| Product presentation | Formulation, strength and fill | P.1 and proposed labeling |
| Contact components | Material, grade/coating where relevant, component identifier | Specifications and supplier records |
| Functional components | Protective or delivery role | P.2 suitability evidence |
| Drawings and controls | Relevant dimensions, methods and revision | Actual proposed configuration |
| Supporting studies | Exact tested configuration | Stability and use/compatibility assessments |
Do not replace a material identity with an appearance description. “Same vial system” can hide differences in elastomer, coating or fill that matter to the scientific assessment. Conversely, do not duplicate all evidence automatically when the technical team has established a justified shared scope; explain that scope.
Review exercise: one carton is described as decorative in P.7, while the photostability discussion relies on it for protection. Resolve its actual function and reconcile the packaging description, supporting study and proposed handling instructions. Direct product contact is not the only reason a component may matter.
Use P.2 development for the suitability argument and P.8 stability for time-dependent evidence. If a delivery device is part of the system, obtain the relevant regulatory assessment separately rather than implying that P.7 alone resolves every device question.
Your preparation checklist
0/3 checkedUse this to track your review in this visit. Checks are not saved and do not establish regulatory compliance.
Frequently asked questions
How do P.7 and P.2.4 differ?
P.7 identifies and describes the container-closure system and its applicable controls. P.2.4 explains its suitability for the product during storage, transport and use. Cross-reference the evidence and keep component identities consistent, rather than maintaining contradictory descriptions and conclusions.
Can visually identical stoppers be treated as equivalent?
Do not infer material equivalence from appearance. Check the controlled component identity, material or coating and the relevant supporting assessment. Where proposed systems differ, preserve that distinction until packaging and formulation experts establish what information and evidence can be shared.
Can a protective carton be omitted because it does not contact the product?
No. Its function may matter to the product’s protection even without direct contact. Distinguish functional secondary packaging from nonfunctional packaging and provide the information needed to understand the actual system and its relationship to the supporting evidence.
Sources and revisions
Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.
Guidance
ICH M4Q(R1): CTD Quality ↗Step 4, September 12, 2002; Module 3, printed pages 5–18. Organization/content guidance, not a universal list of required studies. Checked September 22, 2026. Guide-specific passages: 3.2.P.7, printed pages 15–16.
Technical specification · placement only
FDA eCTD v4.0 comprehensive hierarchy ↗Version 2.2, February 2025. Section 3.2.P.7. A heading identifies placement, not mandatory applicability.